XML 32 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1

Accrued Expenses

3 Months Ended

12 Months Ended

Mar. 31, 2018

Dec. 31, 2017

Payables and Accruals [Abstract]

Accrued Expenses

(5) Accrued Expenses

Accrued expenses consist of the following:

(in thousands)		March 31, 2018				December 31, 2017
Compensation, excluding taxes		$	738			$	1,124
Clinical trial expenses			1,603				869
Professional fees			95				221
Short-term portion of lease restructuring			197				209
Other1			893				985
Total accrued expenses		$	3,526			$	3,408

¹  Other consists of various accrued expenses, with no individual item accounting for more than 5% of current liabilities at March 31, 2018 and December 31, 2017.

(7) Current Accrued Expenses

Current accrued expenses include the following:

(in thousands)		December 31, 2017				December 31, 2016
Clinical trial expenses		$	869			$	1,365
Compensation, excluding taxes			1,124				933
Professional fees			221				286
Short-term portion of lease restructuring			209				216
Other1			985				607
Total accrued expenses		$	3,408			$	3,407

¹  Other consists of various accrued expenses, with no individual item accounting for more than 5% of current liabilities at December 31, 2017 and 2016.

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration